published meta-analysis   sensitivity analysis   studies

corticosteroids in COVID 19 all comers - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsTang X, 2020 0.98 [0.93; 1.02] 0.98[0.93; 1.02]Tang X, 202010%86NAnot evaluable deathsdetailed resultsTang X, 2020 0.98 [0.93; 1.02] 0.98[0.93; 1.02]Tang X, 202010%86NAnot evaluable clinical deteriorationdetailed resultsTang X, 2020 1.00 [0.13; 7.45] 1.00[0.13; 7.45]Tang X, 202010%86NAnot evaluable clinical improvementdetailed resultsTang X, 2020 1.04 [0.67; 1.62] 1.04[0.67; 1.62]Tang X, 202010%86NAnot evaluable clinical improvement (14-day)detailed resultsTang X, 2020 1.33 [0.57; 3.11] 1.33[0.57; 3.11]Tang X, 202010%86NAnot evaluable clinical improvement (time to event analysis only)detailed resultsTang X, 2020 1.04 [0.67; 1.62] 1.04[0.67; 1.62]Tang X, 202010%86NAnot evaluable viral clearance detailed resultsTang X, 2020 1.78 [1.06; 3.00] 1.78[1.06; 3.00]Tang X, 202010%86NAnot evaluable viral clearance (time to event analysis only)detailed resultsTang X, 2020 1.78 [1.06; 3.00] 1.78[1.06; 3.00]Tang X, 202010%86NAnot evaluable ICU admissiondetailed resultsTang X, 2020 1.00 [0.13; 7.45] 1.00[0.13; 7.45]Tang X, 202010%86NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-03-29 07:59 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 94 - treatments: 522,582,666,1149,1150,737,544,733 - roots T: 290